AbbVie and Xilio Therapeutics, Inc., a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced a collaboration...
CSafe , a provider of active and passive temperature-controlled shipping solutions for the biopharmaceutical industry, proudly announces the launch of a new line of multi-purpose...
Arcellx, Inc., a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, announced that...
Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, announced the kick-off of their participation in the prestigious Hospital-University Research in Health (RHU) program. Designed...
Basel, announced that new data from its extensive haematology portfolio will be presented at the American Society of Hematology (ASH) Annual Meeting and Exposition...
